[go: up one dir, main page]

AR045516A1 - Procedimiento para la sintesis de perindopril y de sus sales farmeceuticamente aceptables - Google Patents

Procedimiento para la sintesis de perindopril y de sus sales farmeceuticamente aceptables

Info

Publication number
AR045516A1
AR045516A1 ARP040103079A ARP040103079A AR045516A1 AR 045516 A1 AR045516 A1 AR 045516A1 AR P040103079 A ARP040103079 A AR P040103079A AR P040103079 A ARP040103079 A AR P040103079A AR 045516 A1 AR045516 A1 AR 045516A1
Authority
AR
Argentina
Prior art keywords
formula
synthesis
acceptable salts
compound
perindopril
Prior art date
Application number
ARP040103079A
Other languages
English (en)
Inventor
Thierry Dubuffet
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR045516A1 publication Critical patent/AR045516A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Procedimiento para la síntesis de los compuestos de fórmula (1) y de sus sales farmacéuticamente aceptables, caracterizado porque se hace reaccionar el compuesto de fórmula (2) en la cual Bn representa un grupo bencilo, con un compuesto de fórmula (3) de configuración S; en la cual X representa un átomo de halógeno y BOC representa un grupo terc-butoxicarbonilo, en presencia de una base, para obtener, después de la desprotección de la función amino, el compuesto de fórmula (4) en la cual Bn representan un grupo bencilo, que se somete a reacción con 2-oxopentanoato de etilo bajo una presión de H, en presencia de platino sobre C, para obtener el compuesto de fórmula (1).
ARP040103079A 2003-08-29 2004-08-27 Procedimiento para la sintesis de perindopril y de sus sales farmeceuticamente aceptables AR045516A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03292132A EP1380591B1 (fr) 2003-08-29 2003-08-29 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
AR045516A1 true AR045516A1 (es) 2005-11-02

Family

ID=29724624

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103079A AR045516A1 (es) 2003-08-29 2004-08-27 Procedimiento para la sintesis de perindopril y de sus sales farmeceuticamente aceptables

Country Status (18)

Country Link
US (1) US7534896B2 (es)
EP (1) EP1380591B1 (es)
JP (1) JP4331206B2 (es)
CN (1) CN100383160C (es)
AR (1) AR045516A1 (es)
AT (1) ATE310012T1 (es)
AU (1) AU2004270428B2 (es)
DE (1) DE60302287T2 (es)
DK (1) DK1380591T3 (es)
EA (1) EA008668B1 (es)
ES (1) ES2252633T3 (es)
HK (1) HK1096408A1 (es)
MY (1) MY136638A (es)
NZ (1) NZ545336A (es)
PL (1) PL211508B1 (es)
SI (1) SI1380591T1 (es)
WO (1) WO2005023842A1 (es)
ZA (1) ZA200601429B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1371659T1 (sl) * 2003-08-29 2006-02-28 Servier Lab Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
ATE409036T1 (de) 2005-01-06 2008-10-15 Ipca Lab Ltd Verfahren zur synthese von (2s,3as,7as)-1-(s)- alanyl-octahydro-1h-2-carbonsäurederivaten und verwendung in der synthese von perindopril
ES2552653T3 (es) 2008-06-24 2015-12-01 Mylan Laboratories Limited Formas polimórficas novedosas de (l)-arginina de perindoprilo y proceso para la preparación de las mismas
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
JP6753699B2 (ja) * 2016-05-27 2020-09-09 ミネベアミツミ株式会社 転がり軸受

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1321471E (pt) 2003-03-12 2005-07-29 Servier Lab Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico
DE60300106T2 (de) * 2003-03-12 2005-10-13 Les Laboratoires Servier Verfahren zur Synthese von (2S,3aS,7aS)-1-((S)-Alanyl)-octahydro-1H-indol-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
DK1367061T3 (da) * 2003-06-30 2006-05-15 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
EP1380590B1 (fr) * 2003-08-29 2006-09-06 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
SI1371659T1 (sl) * 2003-08-29 2006-02-28 Servier Lab Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
ES2282586T3 (es) * 2003-11-19 2007-10-16 Les Laboratoires Servier Procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables.

Also Published As

Publication number Publication date
ES2252633T3 (es) 2006-05-16
US20070010572A1 (en) 2007-01-11
EA200600454A1 (ru) 2006-08-25
US7534896B2 (en) 2009-05-19
ZA200601429B (en) 2007-05-30
PL211508B1 (pl) 2012-05-31
MY136638A (en) 2008-11-28
DE60302287D1 (de) 2005-12-22
EA008668B1 (ru) 2007-06-29
CN1835966A (zh) 2006-09-20
CN100383160C (zh) 2008-04-23
EP1380591A1 (fr) 2004-01-14
WO2005023842A1 (fr) 2005-03-17
HK1096408A1 (en) 2007-06-01
DK1380591T3 (da) 2006-01-23
AU2004270428A1 (en) 2005-03-17
EP1380591B1 (fr) 2005-11-16
NZ545336A (en) 2009-03-31
DE60302287T2 (de) 2006-08-10
PL379628A1 (pl) 2006-10-30
JP4331206B2 (ja) 2009-09-16
AU2004270428B2 (en) 2008-08-21
SI1380591T1 (sl) 2006-02-28
ATE310012T1 (de) 2005-12-15
JP2007526902A (ja) 2007-09-20

Similar Documents

Publication Publication Date Title
CY1110986T1 (el) Αζολια ως αναστολεις της αποκαρβοξυλασης μηλονυλο-συνενζυμου α χρησιμα ως μεταβολικοι διαμορφωτες
AR034897A1 (es) Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
AR048213A1 (es) 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol
CY1108894T1 (el) Νεα παραγωγα βενζιμιδαζολης
CY1106544T1 (el) Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης
CY1106471T1 (el) Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης
AR045516A1 (es) Procedimiento para la sintesis de perindopril y de sus sales farmeceuticamente aceptables
AR045517A1 (es) Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables
AR044453A1 (es) Derivados de metoxi-pirazin-tienil sulfonamida
CO5700735A2 (es) Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas
AR077476A2 (es) Derivados antagonistas del receptor de la vitronectina, procedimiento de preparacion, composiciones farmaceuticas y usos de los compuestos
PE20021016A1 (es) Conjugados de pregabalina-lactosa
AR045515A1 (es) Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
ES2172376B1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR044175A1 (es) Compuestos de cefemo
AR027782A1 (es) Nuevo procedimiento para la sintesis de los esteres de n-[(s)-1-carboxibutil]-(s)-alanina y su aplicacion en la sintesis del perindoprilo
AR046768A1 (es) Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas
EA200501257A1 (ru) Новый способ синтеза соединений (2s,3as,7as)-1-[(s)-аланил]октагидро-1h-индол-2-карбоновой кислоты и их применение для синтеза периндоприла
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
AR044672A1 (es) Compuestos de benzotiazina y benzotiadiazina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR045727A1 (es) Fluorocombretastatina y derivados de la misma
AR047245A1 (es) Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables
EA200501256A1 (ru) НОВЫЙ СПОСОБ СИНТЕЗА (2S,3aS,7aS)-ПЕРГИДРОИНДОЛ-2-КАРБОНОВОЙ КИСЛОТЫ И ЕЁ СЛОЖНЫХ ЭФИРОВ, А ТАКЖЕ ИХ ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ПЕРИНДОПРИЛА

Legal Events

Date Code Title Description
FA Abandonment or withdrawal